What is Aidoc?

What is Aidoc?

Aidoc is a clinical imaging ai company headquartered in Tel Aviv, Israel.

Aidoc's imaging AI is used by more than 900 hospitals and imaging centers, with dozens of FDA clearances across acute-care use cases. Reported customers include large hospital systems and imaging groups such as Yale New Haven, Cedars-Sinai, University of Rochester Medical Center, and Sheba Medical Center.

The company was founded in 2016 and remains private; ipo discussed by ceo in 2026 coverage. Its public profile is strongest around aiOS platform and Radiology triage algorithms, while detailed revenue figures are not publicly disclosed.

As of June 2026, the safest public read is that Aidoc is scaling through enterprise partnerships and capital-intensive product development rather than a self-serve consumer motion.

Sources:Aidoc websiteAxios Aidoc Series E coverage

What does Aidoc offer?

Aidoc's public product set centers on aiOS platform, Radiology triage algorithms, CARE1 foundation model.

Sources:Aidoc website

How does Aidoc make money?

Enterprise clinical AI software sold to hospitals and radiology networks; public pricing is not disclosed.

Enterprise clinical AI software sold to hospitals and radiology networks; public pricing is not disclosed. No public list pricing; sold through enterprise clinical procurement.

Growth is driven by enterprise adoption, strategic partnerships, and proof that the platform can deliver measurable operational, clinical, scientific, or mission outcomes. Because Aidoc does not publish standard list prices, buyers should treat budget sizing as a custom-contract exercise.

The commercial motion therefore depends on executive sponsorship, security and compliance review, and evidence that the product can integrate into existing workflows rather than replace them all at once.

Sources:Aidoc websiteWikipedia Aidoc summary

Who leads Aidoc?

Aidoc is led by Elad Walach, Co-founder and CEO.

Sources:Aidoc websiteAxios Aidoc Series E coverage

How do you contact Aidoc's leadership?

Public contact form; no verified personal email pattern found. Use the listed public company route rather than guessed personal inboxes.

Sources:Aidoc website

How much funding has Aidoc raised?

Aidoc has about $370 million reported before the 2026 series e; over $500 million with 2026 financing and is private; ipo discussed by ceo in 2026 coverage.

2017: Seed — $7 million, led/backed by TLV Partners. 2019: Series B — $27 million, led/backed by Square Peg. 2021: Series C — $66 million, led/backed by General Catalyst. 2022: Series D — $110 million, led/backed by TCV and Alpha Intelligence Capital. 2026: Series E — $150 million, led/backed by Goldman Sachs Alternatives (Valuation undisclosed).

The latest public valuation/status marker is Undisclosed. Where a valuation is undisclosed, public reporting only supports the financing amount and participating investors.

Funding is best interpreted as capacity for product build-out, hiring, regulatory or deployment work, and longer sales cycles; it should not be read as proof of profitability unless the company has separately disclosed profitability.

Sources:Axios Aidoc Series E coverageWikipedia Aidoc summary

How did Aidoc get here?

Aidoc's timeline runs from its 2016 founding through major financing and product milestones.

Sources:Aidoc websiteAxios Aidoc Series E coverage

Who are Aidoc's competitors?

Aidoc competes with specialized startups and larger platform companies in clinical imaging ai.

Sources:Aidoc websiteWikipedia Aidoc summary